trial · primary record
Biospecimen Collection
Recurrent Langerhans Cell Histiocytosis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 48 |
| Primary completion | 2028-09-30 |
| Primary endpoint | Frequency of dose limiting toxicity (dose finding phase) |
| Registry ID | NCT05828069 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:05.145Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05828069
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Biospecimen Collection · compound